CLINICAL ROLE -
Positive Results Show Blood-Based Screening Test Detected Colorectal Cancer
The test’s sensitivity in distinguishing colorectal cancer, in combination with real-world adherence, showed its ability to detect cancer at a curable stage.
Read More
FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer
PT886 (Phanes Therapeutics) received fast track designation 2 years after receiving orphan drug designation by the FDA.
An FDA Perspective on Improving Workplace Mental Health and Wellbeing
An FDA executive discusses the Surgeon General’s recommendations for promoting mental health and wellbeing for employees in the workplace.
Addressing Obesity Through Shared Decision Making in an Interdisciplinary Weight Management Clinic
A pharmacist discusses the impact of comprehensive weight management with a shared decision making approach.
The Role of the Pharmacist in Long-Acting Injectable Therapies for Schizophrenia and Bipolar Disorder
These therapies can improve treatment adherence for patients, especially for those with a history of poor or uncertain adherence.
Pharmacy Technicians, Advanced Techs Can Do More in the Pharmacy
Studies have shown that the presence of advanced pharmacy technicians in a pharmacy has a positive predictive validity to increased monthly immunizations.
Pharmacists Can Play Vital Role in Improving Access to Nutritious Foods
Food pharmacies, in particular, can be a great opportunity for pharmacists to collaborate with other providers, improve access to nutritious foods, and find unique opportunities to counsel patients.
Watch
Pharmacists' Vital Role in RSV Vaccination: Shared Clinical Decision Making and Education
Shared decision making with patients is a key component of RSV vaccination, which can bring challenges and opportunities.
Changing Mindset Is Crucial for Clinicians to Effectively Implement New Weight Management Medications
In addition to improved efficacy, newer generations of anti-obesity medications have significantly improved safety concerns.
Expert Reviews New Data, Updates in Psychedelic Medicines
Sa'ed Al-Olimat, PharmD, also discussed the potentially groundbreaking shift for MDMA expected later in 2024.
Expert: Pharmacogenomics Could Be Particularly Beneficial in the Psychiatric Setting
Pharmacogenomics could help streamline prescribing and dosing for psychiatric medications, avoiding the trial-and-error process common with these medications.
Navigating Cannabis in Pharmacy Practice: State Legislation and Contraindications for Patient Use
Pharmacists can educate patients on current clinical evidence of cannabis’s therapeutic benefit, as well as cannabis’s complexities, risks, and potential adverse effects.
Maintain a Patient-Centered Approach When Developing Clinical Recommendations for Weight Management Medications
Expert Jennifer Clements discussed the evolving landscape of weight management medications, clinical considerations, and obstacles to use.
FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins
Bempedoic acid (Nexletol; Esperion) and bempedoic acid and ezetimibe (Nexlizet; Esperion) are the only LDL-C lowering non-statin drugs indicated for primary prevention patients.
FDA Approves Mirvetuximab Soravtansine-Gynx for Patients With Certain Ovarian Cancers
The treatment is indicated for patients with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.
As Cannabis Use Increases, Pharmacists Must Be Prepared to Counsel Patients
As more states have legalized cannabis use—both medicinal and recreational—Sera said pharmacists’ roles in counseling will become even more important.
Pharmacists Should Prioritize Inclusivity, Provide Gender-Affirming Care
Holloway discusses gender-affirming care, the challenging current legal landscape, and in particular how pharmacists can best serve their patients who are transgender or gender diverse.
AstraZeneca to Initiate Trial for Triple-Combination Inhaled Therapy for Chronic Obstructive Pulmonary Disease
The company has announced that the first participants have also been dosed in the ATHLOS phase 3 clinical trial, investigating budesonide/glycopyrronium/formoterol fumarate (Breztri Aerosphere).
V116 Demonstrates Positive Immunogenicity for 21 Pneumococcal Serotypes
Positive data were presented at the 13th Meeting of the International Society of Pneumonia and Pneumococcal Disease in Cape Town, South Africa.
AI, Machine Learning Can Bring Significant Benefits to Pharmaceutical Development, Research
Identifying the best uses for these tools, whether in patient education, data collection, improving efficiencies, or other uses, could significantly improve the future of pharmacy.
Community Pharmacy Can Help Solve Health Equity Challenges in Clinical Research
A lack of equity in clinical research has direct impacts on patient care and outcomes
Pharmacists Make Positive Impact Through Clinical Interventions
Providing evidence-based literature and resolving medication-related problems are strategies for improving acceptance of clinical recommendations
FDA Approves Givinostat as First Nonsteroidal Drug for Duchenne Muscular Dystrophy
The FDA recommends the dosage of givinostat (Duvyzat; Italfarmaco, ITF Therapeutics) should be based on the individual’s body weight and administered twice daily with food.
As Access to Contraception Expands, Pharmacists Can Play a Key Role
Lakdawala and Vernon’s session discusses the changing landscape of hormonal contraception and pharmacists’ roles within it.
Cranberry Supplementation Can Boost Athletic Performance During Strenuous Exercise
Cranberry extract improved speed in the 1500-meter time trial by 1.5%.
Study: PCR-Based Testing Results in Faster, Targeted Treatment for Community-Acquired Pneumonia
When considering community-acquired pneumonia alone, the PCR test identified 113 bacterial detections compared with 57 for the standard of care test.
Study Data Suggests Sustained Safety, Efficacy of Lanadelumab in Adolescents With HAE
The data comes from 2 phase 4 trials, ENABLE and EMPOWER, which evaluated lanadelumab and the outcomes of treatment in adolescents with hereditary angioedema.
FDA Approves Rilpivirine for Treatment of HIV for Pediatric Patients 2 and Older
Rilpivirine (Edurant Ped; Johnson and Johnson) is indicated for the treatment of HIV in combination with other antiretroviral therapies in treatment-naïve pediatric patients.
Precision in Practice: Optimizing Probability of Beta-Lactam Target Attainment with Prolonged Infusions and Therapeutic Drug Monitoring
As data continue to develop in this arena, β-lactam therapeutic drug monitoring is likely to become more routine, as it has with drugs like vancomycin and the aminoglycosides.
FDA Approves Aprocitentan for Treatment of Hypertension in Combination With Other Drugs
The FDA has only approved aprocitentan (Tryvio; Idorsia) in the 12.5 mg dosage as the effects were similar between the 25 mg and 12.5 mg dosages.